Aker BioMarine’s Science Board Meets to Talk Krill
Among items discussed, the Aker BioMarine Science Board (ABS) talked about existing data supporting krill oil and omega-3 phospholipids, as well as ongoing clinical trials with Aker BioMarine’s Superba krill oil and global increases in omega-3 consumption and supplementation.
At its first meeting at the beginning of October, Aker BioMarine’s (Oslo, Norway) new science board met to discuss the future of krill phospholipid omega-3s.
Among items discussed, the Aker BioMarine Science Board (ABS) talked about existing data supporting krill oil and omega-3 phospholipids, as well as ongoing clinical trials with Aker BioMarine’s Superba krill oil and global increases in omega-3 consumption and supplementation.
Aker says that its board will provide the company with strategic guidance on ongoing research and product development, including in vitro, preclinical, and clinical studies.
